EditorialEditorial
Cancer immunology and immunotherapy
Xiubao Ren
Cancer Biology & Medicine November 2021, 18 (4) 931-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0036
Xiubao Ren
1Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
2Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
3Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin 300060, China
References
- 1.↵
- 2.↵
- Das S,
- Johnson DB.
- 3.↵
- 4.↵
- Liu L,
- Gao QL,
- Jiang JT,
- Zhang JP,
- Song X,
- Cui JW, et al.
In this issue
Cancer immunology and immunotherapy
Xiubao Ren
Cancer Biology & Medicine Nov 2021, 18 (4) 931-933; DOI: 10.20892/j.issn.2095-3941.2021.0036
Jump to section
Related Articles
- No related articles found.